Immuneering Corporation is seeking a seasonedClinical Pharmacologist to lead CP strategy across early to pivotal development, integrating PK/PD, exposure–response, and biomarkers to inform dose selection and trial design.
This individual contributor role requires deep expertise in MIDD, regulatory submissions (IND/IMPD/NDA), and cross-functional collaboration with Biostatistics, Data Science, and Regulatory teams to drive decisive go/no-go decisions.
#J-18808-LjbffrPrincipal Clinical Pharmacology Scientist – MIDD/PKPD in new york at Unknown Company
This position is listed as full time and onsite.